Difficulty: Medium
Average Score: 83%
Practice
A 19-year-old man with a significant seizure history has various seizures including partial onset seizures, myoclonic seizures, and, occasionally, primary generalized tonic-clonic seizures. His physician prescribed levetiracetam. This agent likely works on which of the following structures?
Correct answer
C
Rationale
Levetiracetam is an antiepileptic drug that is believed to act on synaptic vesicle protein SV2A. This protein is involved in the regulation of neurotransmitter release, particularly in the context of epileptic activity. By binding to SV2A, levetiracetam modulates neurotransmitter release, thereby reducing the likelihood of abnormal neuronal firing associated with seizures.
Option A, Calcium channel modulation, is incorrect in this context because levetiracetam does not primarily target calcium channels. While calcium channels play a role in neuronal excitability, the mechanism of action of levetiracetam is not centered on calcium channel modulation.
Option B, Collapsing response mediator protein-2, is also incorrect as levetiracetam does not directly interact with this protein in the treatment of seizures.
Option D, Sodium channels, is a common target for many antiepileptic drugs, but levetiracetam's mechanism of action is distinct from sodium channel blockade.
In an educational context, understanding the specific pharmacological target of levetiracetam can help healthcare professionals make informed decisions regarding its use in patients with seizure disorders. Knowledge of drug mechanisms also aids in rational prescribing practices and enhances patient safety and treatment outcomes.
Option A, Calcium channel modulation, is incorrect in this context because levetiracetam does not primarily target calcium channels. While calcium channels play a role in neuronal excitability, the mechanism of action of levetiracetam is not centered on calcium channel modulation.
Option B, Collapsing response mediator protein-2, is also incorrect as levetiracetam does not directly interact with this protein in the treatment of seizures.
Option D, Sodium channels, is a common target for many antiepileptic drugs, but levetiracetam's mechanism of action is distinct from sodium channel blockade.
In an educational context, understanding the specific pharmacological target of levetiracetam can help healthcare professionals make informed decisions regarding its use in patients with seizure disorders. Knowledge of drug mechanisms also aids in rational prescribing practices and enhances patient safety and treatment outcomes.